MedTrace Logo

Treatment to Promote Self-regulation in Children With Autism Spectrum Disorder

NCT05235919 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-07-26

No results posted yet for this study

Summary

This study will evaluate the feasibility of repetitive Transcranial Magnetic Stimulation (rTMS) in Autism Spectrum Disorder (ASD) with self-regulation impairment. Baseline and follow-up participant visits will include behavioral assessments of self-regulation and magnetic resonance imaging (MRI) to determine neurophysiological outcomes before and after rTMS treatment.

Conditions

Interventions

DEVICE

repetitive transcranial magnetic stimulation (rTMS)

30 minutes rTMS session 5 days/week for 3 weeks.

OTHER

Sham stimulation

30 minutes sham stimulation 5 days/week for 3 weeks.

Sponsors & Collaborators

  • Centre for Addiction and Mental Health

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • Holland Bloorview Kids Rehabilitation Hospital

    lead OTHER

Principal Investigators

  • Deryk Beal, PhD · Holland Bloorview Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-22
Primary Completion
2025-02-28
Completion
2025-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05235919 on ClinicalTrials.gov